CRNX
Price
$38.79
Change
+$0.14 (+0.36%)
Updated
Jan 23, 03:57 PM (EDT)
Capitalization
3.58B
54 days until earnings call
ELVN
Price
$22.25
Change
+$0.20 (+0.91%)
Updated
Jan 23, 03:55 PM (EDT)
Capitalization
1.08B
49 days until earnings call
Ad is loading...

CRNX vs ELVN

Header iconCRNX vs ELVN Comparison
Open Charts CRNX vs ELVNBanner chart's image
Crinetics Pharmaceuticals
Price$38.79
Change+$0.14 (+0.36%)
Volume$1.8K
Capitalization3.58B
Enliven Therapeutics
Price$22.25
Change+$0.20 (+0.91%)
Volume$100
Capitalization1.08B
CRNX vs ELVN Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. ELVN commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and ELVN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (CRNX: $38.65 vs. ELVN: $22.05)
Brand notoriety: CRNX and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 213% vs. ELVN: 93%
Market capitalization -- CRNX: $3.58B vs. ELVN: $1.08B
CRNX [@Biotechnology] is valued at $3.58B. ELVN’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and ELVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while ELVN’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 2 bearish.
  • ELVN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ELVN.

Price Growth

CRNX (@Biotechnology) experienced а +5.23% price change this week, while ELVN (@Biotechnology) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.05%. For the same industry, the average monthly price growth was +3.28%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

CRNX is expected to report earnings on May 08, 2025.

ELVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.58B) has a higher market cap than ELVN($1.08B). ELVN YTD gains are higher at: -2.000 vs. CRNX (-24.408). ELVN has higher annual earnings (EBITDA): -100.07M vs. CRNX (-304.51M). CRNX has more cash in the bank: 863M vs. ELVN (292M). ELVN has less debt than CRNX: ELVN (85K) vs CRNX (52.5M). CRNX has higher revenues than ELVN: CRNX (1.04M) vs ELVN (0).
CRNXELVNCRNX / ELVN
Capitalization3.58B1.08B333%
EBITDA-304.51M-100.07M304%
Gain YTD-24.408-2.0001,220%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash863M292M296%
Total Debt52.5M85K61,765%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXELVN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 16 days ago
82%
Bearish Trend 16 days ago
89%
Momentum
ODDS (%)
Bearish Trend 16 days ago
79%
Bullish Trend 16 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 16 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
78%
Bullish Trend 16 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
76%
Bullish Trend 16 days ago
86%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 16 days ago
89%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQEPX23.470.28
+1.21%
GQG Partners US Select Quality Eq Inv
MUOCX28.760.32
+1.13%
Morgan Stanley Instl US Core C
TSLTX5.18N/A
N/A
Transamerica Small Cap Value I3
MPEGX23.00-0.06
-0.26%
Morgan Stanley Inst Discovery I
VMCPX373.24-1.10
-0.29%
Vanguard Mid Cap Index InstitutionalPlus

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with MRSN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.28%
MRSN - CRNX
49%
Loosely correlated
-4.07%
ELVN - CRNX
48%
Loosely correlated
+0.23%
ARWR - CRNX
48%
Loosely correlated
-0.25%
TRDA - CRNX
46%
Loosely correlated
-3.98%
DYN - CRNX
46%
Loosely correlated
-3.02%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.23%
CRNX - ELVN
48%
Loosely correlated
-0.28%
OCEA - ELVN
48%
Loosely correlated
-3.12%
VYGR - ELVN
38%
Loosely correlated
+4.02%
ACLX - ELVN
38%
Loosely correlated
-1.08%
BPMC - ELVN
37%
Loosely correlated
-0.79%
More